CSIMarket
 
Neurometrix Inc   (NURO)
Other Ticker:  
 
 

Neurometrix Inc's Suppliers Performance

NURO's Supply Chain

 
NURO Costs vs Sales of Suppliers Growth Neurometrix Inc's cost of sales deteriorated by -21.55 % year on year, sequentially cost of sales grew by 14.92 % in Q4.

More on NURO Suppliers




Neurometrix Inc's cost of sales deteriorated by -21.55 % year on year, sequentially cost of sales grew by 14.92 % in Q4.

More on NURO Suppliers



  News about Neurometrix Inc Contracts

NeuroMetrix's Strategic Review Sets Path for Neurological Innovation and Growth

NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder ValueWOBURN, Mass., Feb. 13, 2024 - NeuroMetrix, Inc. (Nasdaq: NURO), a leading medical device company specializing in reducing the impact of neurological disorders and pain syndromes through innovative non-invasive medical devices, has recently announced the initiation of a strategic review process. This review aims to identify various options to fuel the growth of its Quell neuromodulation and DPNCheck neurodiagnostic businesses, ultimately maximizing shareholder value.The healthcare industry is continuously evolving, and NeuroMetrix recognizes the need to align its strategic s with the changing landscape to solidi...

Quell Brings Hope: NeuroMetrix's Breakthrough Trial Results Point to Promising Relief for Long COVID Sufferers


NeuroMetrix's Quell Shows Promise in Addressing Long COVID Symptoms
NeuroMetrix, a leading medical technology company, has recently shared promising results from a pilot clinical trial involving its innovative Quell wearable neuromodulation technology. The trial focused on patients suffering from post-acute COVID-19 syndrome, commonly referred to as Long COVID. The presentation of this data marks a significant milestone for the company and offers new hope in managing the lingering symptoms experienced by many individuals after recovering from COVID-19.
Long COVID has emerged as a complex and challenging condition that affects a significant portion of COVID-19 survivors. Patients suffering from t...




Neurometrix Inc's Comment on Supply Chain









NURO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Neurometrix Inc 4.17 4.95 -6.53 -
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com